Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 62.48
+1.38 (2.26%)
Mar 20, 2026, 9:45 AM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 6.68 billion as of March 19, 2026. Its market cap has increased by 59.70% in one year.
Market Cap
6.68B
Enterprise Value
6.56B
Revenue
1.22B
Ranking
n/a
PE Ratio
34.13
Stock Price
62.48
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 6.68B, a decrease of -30.50%. That is a compound annual growth rate of -7.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 6.68B | -1.69% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
| Jun 21, 2021 | 9.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Huiyu Pharmaceutical | 7.42B |
| Dezhan Healthcare Company | 7.40B |
| Sunflower Pharmaceutical Group Co.,Ltd | 7.36B |
| Hunan Jiudian Pharmaceutical | 7.33B |
| Hainan Haiyao | 7.20B |
| Heilongjiang ZBD Pharmaceutical | 6.89B |
| Guizhou Bailing Group Pharmaceutical | 6.89B |
| Tibet Duo Rui Pharmaceutical | 6.61B |